Abstract
Get full access to this article
View all access options for this article.
References
1.
Saltiel
E
Brogden
RN
. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use . Drugs
1986 ; 32 : 222 –59 .
2.
Christ
W
. Pharmacological properties of cephalosporins . Infection
1991 ; 19 (suppl 5 ):S244 –52 .
3.
Jacob
LS
Layne
P
. Cefonicid: An overview of clinical studies in the United States . Rev Infect Dis
1984 ; 6 (suppl 4 ):S791 –802 .
4.
Naranjo
CA
Busto
U
Sellers
EM
Sandor
P
Ruiz
I
Roberts
EA
. A method for estimating the probability of adverse drug reactions . Clin Pharmacol Ther
1981 ; 30 : 239 –45 .
5.
Hatton
MQ
Allen
MB
Mellor
EJ
Cooke
NJ
. Salmeterol rash . Lancet
1991 ; 337 : 1169 –70 .
6.
Farrell
GC
. Liver disease caused by drugs, anesthetics, and toxins . In:
Feldman
M
Sleisinger
MH
Scharschmidt
BF
Klein
S
, eds. Sleisinger and Fordtran's gastrointestinal and liver disease: Pathophysiology, diagnosis, management . 6th ed.
Philadelphia : WB Saunders , 1998 : 1221 –53 .
7.
Kunkel
MJ
Iannini
PB
. Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting . Rev Infect Dis
1984 ; 6 (suppl 4 ):S865 –9 .
8.
Monerris
H
Horga
JF
Perez-Mateo
M
. Hypoprothrombinemia associated with cefonicid . Med Clin (Barc)
1995 ; 104 : 237 –8 .
9.
Riancho
JA
Olmos
JM
Sedano
C
. Life-threatening bleeding in a patient treated with cefonicid . Ann Intern Med
1995 ; 123 : 472 –3 .